Organization Profile

You just read:

TauRx Therapeutics Achieves Enrollment Target in the First of Its Two Phase III Clinical Trials of LMTX(TM) in Alzheimer's Disease

News provided by

MediciGlobal

Jul 16, 2014, 17:17 ET